secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beta Bionics, Inc. (BBNX)
CIK:        0001674632
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001171843-25-004016
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beta Bionics reports real-world iLet data: HbA1c drops from 8.9% to 7.3% in 14,952 users
--------------------------------------------------------------------------------

- 16,439 iLet users uploaded data in first 2 years; 14,952 with baseline HbA1c showed avg drop from 8.9% to 7.3% GMI.
- 8,802 prior MDI users improved from 9.2% to 7.3%; 2,910 prior HCL users improved from 8.1% to 7.3%.
- 2,416 'fully-closed loop' users (≤1 meal announcement/day) improved from 9.4% to 7.5% GMI; 83% met ADA hypoglycemia goals.
- Adaptive algorithm reaches steady state in ~2 days; similar outcomes seen in primary care and endocrinology practices.
- Company highlights pharmacy channel strategy and bionic portal for HCPs; no financial guidance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/0001171843-25-004016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/f8k_062225.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-004016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer